- Home
- CAPT vs PRPO Comparison
CAPT vs PRPO Comparison
Compare CAPT & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPT
- PRPO
- Stock Information
- Founded
- CAPT 2005
- PRPO N/A
- Country
- CAPT South Korea
- PRPO United States
- Employees
- CAPT N/A
- PRPO N/A
- Industry
- CAPT Blank Checks
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- CAPT Finance
- PRPO Industrials
- Exchange
- CAPT Nasdaq
- PRPO Nasdaq
- Market Cap
- CAPT 31.2M
- PRPO 30.2M
- IPO Year
- CAPT N/A
- PRPO N/A
- Fundamental
- Price
- CAPT $0.83
- PRPO $19.74
- Analyst Decision
- CAPT
- PRPO
- Analyst Count
- CAPT 0
- PRPO 0
- Target Price
- CAPT N/A
- PRPO N/A
- AVG Volume (30 Days)
- CAPT 154.6K
- PRPO 17.5K
- Earning Date
- CAPT 01-01-0001
- PRPO 11-05-2025
- Dividend Yield
- CAPT N/A
- PRPO N/A
- EPS Growth
- CAPT N/A
- PRPO N/A
- EPS
- CAPT N/A
- PRPO N/A
- Revenue
- CAPT $17,389,944.00
- PRPO $21,242,000.00
- Revenue This Year
- CAPT N/A
- PRPO N/A
- Revenue Next Year
- CAPT N/A
- PRPO N/A
- P/E Ratio
- CAPT N/A
- PRPO N/A
- Revenue Growth
- CAPT 84.70
- PRPO 27.05
- 52 Week Low
- CAPT $0.37
- PRPO $3.90
- 52 Week High
- CAPT $1.94
- PRPO $22.38
- Technical
- Relative Strength Index (RSI)
- CAPT 39.02
- PRPO 57.56
- Support Level
- CAPT $0.82
- PRPO $16.40
- Resistance Level
- CAPT $0.86
- PRPO $19.00
- Average True Range (ATR)
- CAPT 0.05
- PRPO 1.31
- MACD
- CAPT 0.00
- PRPO -0.18
- Stochastic Oscillator
- CAPT 10.25
- PRPO 69.13
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.